{"id":1577,"date":"2007-12-31T00:00:42","date_gmt":"2007-12-30T17:00:42","guid":{"rendered":"https:\/\/www.hivnat.org\/dev\/?p=1577"},"modified":"2007-12-31T00:00:42","modified_gmt":"2007-12-30T17:00:42","slug":"publications-in-2007","status":"publish","type":"post","link":"https:\/\/www.hivnat.org\/en\/publications\/1577\/","title":{"rendered":"Publications 2007"},"content":{"rendered":"\n\t\t\t\t\n
  1. Zhou J, Paton NI, Ditangco R, Chen YM, Kamarulzaman A, Kumarasamy N, Lee CK, Li PC, Merati TP, Phanuphak P, Pujari S, Vibhagool A, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG. Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database<\/strong>. HIV Med.<\/a> 2007 Jan;8(1):8-16. <\/li>
  2. Srasuebkul P, Ungsedhapand C, Ruxrungtham K, Boyd MA, Phanuphak P, Cooper DA, Law MG. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment<\/strong>. HIV Med.<\/a> 2007 Jan;8(1):46-54. <\/li>
  3. Buranapraditkun S, Nookhai S, Ubolyam S, Sirivichayakul S, Phanuphak P, Ruxrungtham K. Cost Savings by Reagent Reduction in Flow Cytometry-Based CD4+ T Cell Counts: An Approach to Improve Accessibility for HIV Management<\/strong>. Asian Pac J Allergy Immunol.<\/a> 2007 Mar;25(1):83-9. <\/li>
  4. Kerr SJ, Duncombe C, Avihingsanon A, Ananworanich J, Boyd M, Sopa B, Chuenyam T, Cooper DA, Lange JMA, Phanuphak P, and Ruxrungtham K. Dyslipidaemida in an Asian population following treatment for 2 years with protease inhibitor containing regimens<\/strong>. J Int Assoc Physicians AIDS Care (Chic).<\/a> 2007 Mar;6(1):36-46. <\/li>
  5. ESPRIT Research Group, Fox Z, Antunes F, Davey R, Gazzard B, Klimas N, Labriola A, Losso M, Neaton JD, Phillips AN, Ruxrungtham K, Staszewski S, Weiss L, Lundgren JD. Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count>or=300 cells\/microL who were assigned to 7.5 MIU interleukin-2<\/strong>. HIV Med.<\/a> 2007 Mar;8(2):112-23. <\/li>
  6. Rongkavilit C, Naar-King S, Chuenyam T, Wang B, Wright K, Phanuphak P. Health risk behaviors among HIV-infected youth in Bangkok, Thailand<\/strong>. J Adolesc Health.<\/a> 2007 Apr;40(4):358.e1-8. Epub 2007 Feb 5. <\/li>
  7. Hill A, Ruxrungtham K, Hanvanich M, Katlama C, Wolf E, Soriano V, Milinkovic A, Gatell J, Ribera E. Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment<\/strong>. Expert Opin Pharmacother.<\/a> 2007 Apr;8(5):679-88. <\/li>
  8. Gayet-Ageron A, Ananworanich J, Jupimai T, Chetchotisakd P, Prasithsirikul W, Ubolyam S, Le Braz M, Ruxrungtham K, Rooney J, Hirschel B. No change in calculated creatinine clearance after tenofovir initiation among Thai patients<\/strong>. J Antimicrob Chemother.<\/a> 2007 May;59(5):1034-7. Epub 2007 Mar 21. <\/li>
  9. Langford SE, Ananworanich J, Cooper DA. Predictors of disease progression in HIV infection: a review<\/strong>. AIDS Res Ther.<\/a> 2007 May 14;4:11. <\/li>
  10. Asasutjarit R, Lorenzen SI, Sirivichayakul S, Ruxrungtham K, Ruktanonchai U, Ritthidej GC. Effect of Solid Lipid Nanoparticles Formulation Compositions on Their Size, Zeta Potential and Potential for In Vitro pHIS-HIV-Hugag Transfection<\/strong>. Pharm Res.<\/a> 2007 Jun;24(6):1098-107. Epub 2007 Mar 24. <\/li>
  11. Guidelines for the Clinical Management of HIV Infection in Adults and Adolescents<\/strong>. National AIDS-STD control programme, Department of Health, Ministry of Health Myanmar. Second Edition. 2007 Jun. Editor: Duncombe C.<\/li>
  12. Guidelines for the Clinical Management of HIV Infection in Children<\/strong>. National AIDS-STD control programme, Department of Health, Ministry of Health Myanmar. Second Edition. 2007 Jun. Editor: Duncombe C. <\/li>
  13. Madruga JV, Berger D, McMurchie M, Suter F, Banhegyi D, Ruxrungtham K, Norris D, Lefebvre E, de B\u00e9thune MP, Tomaka F, De Pauw M, Vangeneugden T, Spinosa-Guzman S; TITAN study group. Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial<\/strong>. Lancet.<\/a> 2007 Jul 7;370(9581):49-58. <\/li>
  14. Autar RS, Wit FW, Sankote J, Sutthichom D, Kimenai E, Hassink E, Hill A, Cooper DA, Phanuphak P, Lange JM, Burger DM, Ruxrungtham K. Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients<\/strong>. AIDS.<\/a> 2007 Jul 31;21(12):1535-9. <\/li>
  15. Antiretroviral Therapy for HIV Infection in Adults and Adolescents in Resource-Management of HIV infection and antiretroviral therapy in children<\/strong>. Second edition. Laos PDR. 2007 Aug. Editor: Duncombe C.<\/li>
  16. Management of HIV infection and antiretroviral therapy in adults and adolescents<\/strong>. Second edition. Laos PDR. 2007 Aug. Editor: Duncombe C. <\/li>
  17. Safreed-Harmon K, Siripong A, Kerr SJ, Gruskin S, Pancharoen C and Ananworanich J. Antiretroviral therapy adherence did not differ between Thai children with biological and those with nonbiological parents<\/strong>. Clin Infect Dis.<\/a> 2007 Sep 1;45(5):669-70. <\/li>
  18. Boom JH, K\u00f6sters E, Duncombe C, Kerr SJ, Hirschel B, Ruxrungtham K.; de Mast Q, Kosalaraksa P, Ulbolyam S, Jupimai T, Ananworanich J and The Staccato Study Group. Ferritin levels during structured treatment interruption of HAART<\/strong>. HIV Med.<\/a> 2007 Sep;8(6):388-95.<\/li>
  19. Guidelines for HIV Voluntary Counselling and Testing: A manual for provider and client initiated couselling and testing<\/strong>. Lao PDR. 2007 Sep. Author: Duncombe C. <\/li>
  20. Lai Kim Leng, Chitsanu Pancharoen, Torsak Bunupuradah, Usa Thisyakorn, Panruethai Trinavarat, Darintr Sosothikul, Jintanat Ananworanich. Regression of a cervical spinal mass following highly active antiretroviral therapy (HAART) in a child with advanced human immunodeficiency virus (HIV) disease<\/strong>. J Med Assoc Thai.<\/a> 2007 Sep;90(9):1937-42.<\/li>
  21. Siripong A, Bunupuradah T, Apateerapong W, Boonrak P, Pancharoen C, Ananworanich J. Attitudes of Thai caregivers of children with HIV infection towards HIV disclosure<\/strong>. Vulnerable Children and Youth Studies. 2007 Dec;2(3):191-197. <\/li>
  22. Guidelines for the Clinical management of HIV infection in. Children<\/strong>. World Health Organization<\/a>. 2007. Duncombe C, Editor and Contributing Writer (WHO consultant). <\/li>
  23. Duncombe C, Kerr SJ, Broadhead ML, Paik JY, Ungsedhapand C, Law MG, Ruxrungtham K, Phanuphak P, Lange J, Cooper DA. Immune Recovery and Stopping Cotrimoxazole Prophylaxis in Thai Patients Treated with NNRTI-Based HAART for 216 weeks<\/strong>. AIDS. <\/li>
  24. Vemula S, Kerr S, Pancharoen C, Siripong A, Kosalaraksa P, Engchanil C, Chuamchaitrakool A, Intasan J, Lumbiganond P, Phanuphak P, Ananworanich J. Incidence and Risk Factors for Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)-Related Rash in Thai Children with HIV Infection<\/strong>. J Med Assoc Thai. 2007;90(11):2437-41.<\/li>
  25. Maek-A-Nantawat W, Buranapraditkun S, Klaewsongkram J, Ruxrungthum K. Increased interleukin-17 production both in helper T cell subset Th17 and CD4-negative T cells in human immunodeficiency virus infection<\/strong>. Viral Immunol.<\/a> 2007 Spring;20(1):66-75. <\/li>
  26. Management of HIV Infection and Antiretroviral Therapy in Adults and Adolescents: A Clinical Manual 2007<\/strong>. World Health Organization<\/a>. 2007. Editor: Duncombe C, Contributors: Ananworanich J. <\/li>
  27. Kerr SJ, Ruxrungtham K. Transmission of HIV and its prevention in Asia<\/strong>. Global HIV\/AIDS Medicine. Editors: Sande MA, Volberding PA, and Lange J. Elsevier, Philadelphia. <\/li><\/ol>\n\t\t","protected":false},"excerpt":{"rendered":"

    Zhou J, Paton NI, Ditangco R, Chen YM, Kamarulzaman A, Kumarasamy N, Lee CK, Li PC, Merati TP, Phanuphak P, Pujari S, Vibhagool A, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG. Experience with the use of a first-line regimen of stavudine, lamivudine and… <\/p>\n","protected":false},"author":1,"featured_media":1743,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[23],"tags":[],"class_list":["post-1577","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publications"],"_links":{"self":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/1577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/comments?post=1577"}],"version-history":[{"count":0,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/1577\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/media\/1743"}],"wp:attachment":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/media?parent=1577"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/categories?post=1577"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/tags?post=1577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}